News

Published on 15 Nov 2021 on Benzinga

20 Stocks Moving in Monday's Pre-Market Session


Article preview image

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

NASDAQ.PROG price evolution
AMS.PHIA price evolution
NASDAQ.EYPT price evolution
NASDAQ.MICT price evolution
NYSE.PRG price evolution
NYSE.PHG price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Investors in EyePoint Pharmaceuticals (NASDAQ:EYPT) have unfortunately lost 79% over the last year

It's not a secret that every investor will make bad investments, from time to time. But it's not ...

Simply Wall St. via Yahoo Finance 1 Dec 2022

EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates

EyePoint Pharmaceuticals (EYPT) came out with a quarterly loss of $0.49 per share versus the Zack...

Zacks via Yahoo Finance 2 Nov 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) Has Debt But No Earnings; Should You Worry?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk ...

Simply Wall St. via Yahoo Finance 11 Sep 2022

EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates

EyePoint Pharmaceuticals (EYPT) came out with a quarterly loss of $0.52 per share versus the Zack...

Zacks via Yahoo Finance 3 Aug 2022

EyePoint Pharmaceuticals (EYPT) Soars 21.6%: Is Further Upside Left in the Stock?

EyePoint Pharmaceuticals (EYPT) shares soared 21.6% in the last trading session to close at $9.91...

Zacks via Yahoo Finance 18 Jul 2022

EyePoint Pharma Posts 12-Month Safety, Efficacy Data From Early-Stage Wet AMD Trial

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has announced 12-month data from the Phase 1 DAVIO tr...

Benzinga via Yahoo Finance 15 Jul 2022

7 Wildly Oversold Nasdaq Stocks to Buy Now

In most circumstances, investors should avoid catching a falling knife. However, speculators who ...

InvestorPlace via Yahoo Finance 12 Jul 2022

Chardan Forecasts Over 160% Upside On This Eye Disease-Focused Stock

Chardan has initiated coverage on EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating a...

Benzinga via Yahoo Finance 7 Jul 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) adds US$32m to market cap in the past 7 days, though...

This week we saw the EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) share price climb by 11%. But d...

Simply Wall St. via Yahoo Finance 19 May 2022

Editas' (EDIT) EDIT-301 Gets Orphan Drug Tag for Beta Thalassemia

Editas Medicine, Inc. EDIT announced that the FDA has granted Orphan Drug designation to its inve...

Zacks via Yahoo Finance 13 May 2022